|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-6-15
|
|
pubmed:abstractText |
Chronic obstructive pulmonary disease (COPD) management guidelines recommend regular treatment with one or more long-acting bronchodilators for patients with moderate to severe COPD.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0025-7931
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
414-9
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:16534180-Aged,
pubmed-meshheading:16534180-Bronchodilator Agents,
pubmed-meshheading:16534180-Ethanolamines,
pubmed-meshheading:16534180-Female,
pubmed-meshheading:16534180-Forced Expiratory Volume,
pubmed-meshheading:16534180-Humans,
pubmed-meshheading:16534180-Male,
pubmed-meshheading:16534180-Middle Aged,
pubmed-meshheading:16534180-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:16534180-Safety,
pubmed-meshheading:16534180-Scopolamine Derivatives,
pubmed-meshheading:16534180-Smoking,
pubmed-meshheading:16534180-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD.
|
|
pubmed:affiliation |
Pulmonary Research Institute, Grosshansdorf, Germany. k.richter@pulmoresearch.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
